Costco Wholesale (COST)
933.51
-23.48 (-2.45%)
NASDAQ· Last Trade: Aug 20th, 7:08 PM EDT
Walmart's U.S. sales and traffic missed Wall Street expectations, pressuring shares despite a raised full-year outlook, today, Aug. 20, 2026.
Via The Motley Fool · August 20, 2026
Costco just gave shareholders a 13% dividend raise, but don't expect to retire on the income alone.
Via The Motley Fool · August 20, 2026
Costco has been treading water for the past six months, recording a small loss of 2.7% while holding steady at $958.95. The stock also fell short of the S&P ...
Via StockStory · August 20, 2026
Another big payout from the warehouse club operator should be coming soon.
Via The Motley Fool · August 19, 2026
Costco Wholesale (NASDAQ:COST) has outperformed the market over the past 20 years by 6.81% on an annualized basis producing an average annual return of 16.11%. Currently, Costco Wholesale has a market capitalization of
Via Benzinga · August 19, 2026
Walmart and Costco are aiming to attract consumers with low prices.
Via The Motley Fool · August 18, 2026
Costco stock rose near an early entry buy signal amid news its will sell co-branded Medicare Advantage plans, expanding its array of services.
Via Investor's Business Daily · August 18, 2026
XLP's lower fees and higher dividend yield have driven superior five-year returns, but PBJ offers concentrated food-and-beverage exposure for tactical investors.
Via The Motley Fool · August 18, 2026
Costco plans a limited Medicare rollout with SCAN Group as insurers face rising costs and regulatory scrutiny.
Via Benzinga · August 18, 2026
TJX Companies provides investors with much more value than the bigger-name retail stocks.
Via The Motley Fool · August 17, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via StockStory · August 16, 2026
Costco's valuation looks expensive, but its business keeps delivering.
Via The Motley Fool · August 16, 2026
Costco is lagging the S&P 500 so far this year, but it can still be a long-term winner in a portfolio.
Via The Motley Fool · August 16, 2026
It's easy to be bullish about a company when its shares have produced a total return of 564% in the past decade.
Via The Motley Fool · August 16, 2026
Costco's membership model and consistent growth make it a strong investment candidate, but its high valuation leaves little room for disappointment.
Via The Motley Fool · August 15, 2026
BranchOut Food (NASDAQ:BOF) reported record quarterly net revenue of $4.45 million, while management said investments tied to customer acquisition, expedited shipping and high-cost raw materials weighed on gross margin during the period.
Chief Financial Officer John Dalfonsi said the company’s stra
Via MarketBeat · August 13, 2026
Whether a recession is coming in 2026 or five years from now, the best investors are always figuring out how to prepare.
Via The Motley Fool · August 13, 2026
Analysts don't see MercadoLibre hitting $100 billion in revenue until 2030, but there's a problem with that forecast.
Via The Motley Fool · August 13, 2026
Although Macy's continues to execute its turnaround, warehouse retailer Costco has executed flawlessly for many years.
Via The Motley Fool · August 13, 2026
Procter & Gamble isn't a flashy company, but its dividend will appeal to investors looking for a payout they can count on.
Via The Motley Fool · August 13, 2026
Zenrelia and Credelio Quattro drove blockbuster growth and margin expansion.
Via The Motley Fool · August 12, 2026
Fidelity's broader 104-stock portfolio and lower 0.08% expense ratio deliver superior returns and a 2.2% dividend yield.
Via The Motley Fool · August 11, 2026
FFO grew 4.5% as occupancy hit an all-time high and rent spreads surged.
Via The Motley Fool · August 11, 2026
Buffett has acknowledged that selling all shares was likely a mistake, as the stock rose significantly afterward.
Via The Motley Fool · August 11, 2026
Omada Health (NASDAQ:OMDA) highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships
Via MarketBeat · August 11, 2026